Genor Biopharma Holdings Ltd. filed a next day disclosure return with the Hong Kong Stock Exchange on September 3, 2025. The company issued a total of 1,190,971 new shares. The shares were issued at different prices, with the Chief Executive Officer's share options priced at HKD 1.5 each and eligible employees' share options at HKD 1.808 each.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genor Biopharma Holdings Ltd. published the original content used to generate this news brief on September 03, 2025, and is solely responsible for the information contained therein.